MYC and neoplasm: Furthermore, considering the potential risk of tumor formation upon c‐Myc activation,44 although the Tet‐On‐OSKM mice did not develop tumors as reported,43 we aim to attempt other combinations, bypassing c‐Myc altogether.45, 46